Comparison of somatodendritic and axon terminal dopamine release in the ventral tegmental area and the nucleus accumbens

Neuroscience

Volumn 70, Issue 4, 1996, Pages 1025-1037

  Iravani, M M ^a   Muscat, R ^b   Kruk, Z L ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF MALTA   (Malta)

Author keywords

chemical stimulation; electrical stimulation; fast cyclic voltammetry; somatodendritic release

Indexed keywords

AMPHETAMINE; CEVADINE; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE UPTAKE INHIBITOR; QUINPIROLE; SULPIRIDE; TETRODOTOXIN; VANOXERINE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DENDRITE; DOPAMINE RELEASE; ELECTROSTIMULATION; MALE; NERVE ENDING; NONHUMAN; NUCLEUS ACCUMBENS; POTENTIOMETRY; PRIORITY JOURNAL; RAT; VENTRAL TEGMENTUM;

EID: 0030040193     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-4522(95)00396-7     Document Type: Article

References (98)

1. 1 receptors stimulates accumulation of gamma-aminobutyric acid in slices of the pars reticulata of 6-hydroxydopamine-lesioned rats. Neurosci. Lett. 145, 40-42.
2. Argiolas A., Melis M. R., Fadda F., Serra G. and Gessa G. L. (1982) Effects of dopamine agonists and antagonists on DOPA formation in the substantia nigra. J. Neurochem. 38, 75-79.
3. Bel N. and Artigas F. (1992) Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: an in vivo microdialysis study. Eur. J. Pharmac. 229, 101-103.
4. Benveniste H. (1989) Brain microdiaiysis. J. Neurochem. 52, 1667-1679.
5. Bernardini G. L., Gu X., Viscardi E. and German D. C. (1991) Amphetamine-induced and spontaneous release of dopamine from A9 and A10 cell dendrites: an in vitro electrophysiological study in the mouse. J. neural Transm. gen. Sect. 84, 183-193.
6. Björklund A. and Lindvall O. (1975) Dopamine in dendrites of substantia nigra neurons: suggestions for a role in dendritic terminals. Brain Res. 83, 531-537.
7. Bowery B., Rothwell L. A. and Seabrook G. R. (1994) Comparison between the pharmacology of dopamine receptors mediating the inhibition of cell firing in rat brain slices through the substantia nigra pars compacta and ventral tegmental area. Br. J. Pharmac. 112, 873-880.
8. Bradberry C. W. and Roth R. H. (1989) Cocaine increases extracellular dopamine in rat nucleus accumbens and ventral tegmental area as shown by in vivo microdialysis. Neurosci. Lett. 103, 97-102.
9. Bunney B. S., Aghajanian G. K. and Roth R. H. (1973) Comparison of effects of L-dopa, amphetamine and apomorphine on firing rate of rat dopaminergic neurones. Nature New Biol. 245, 123-125.
10. Bunney B. S., Walters J. R., Roth R. H. and Aghajanian G. K. (1973) Dopaminergic neurons: effect of antipsychotic drugs and amphetamine on single cell activity. J. Pharmac. exp. Ther. 185, 560-571.
11. Castano A., Cano J. and Machado A. (1993) Low selenium diet affects monoamine turnover differentially in substantia nigra and striatum. J. Neurochem. 61, 1302-1307.
12. Cheramy A., Leviel V. and Glowinski J. (1981) Dendritic release of dopamine in the substantia nigra. Nature 289, 537-542.
13. Chevalier G. and Deniau J. M. (1990) Disinhibition as a basic process in the expression of striatal functions. Trends Neurosci. 13, 277-280.
14. Chiodo L. A. and Bunney B. S. (1983) Typical and atypical neuroleptics: differential effects of chronic administration of the activity of A9 and A10 midbrain dopaminergic neurons. J. Neurosci. 3, 1607-1619.
15. Condé H. (1992) Organization and physiology of the substantia nigra. Expl Brain Res. 88, 233-248.
16. Corvaja N., Doucet G. and Bolam J. P. (1993) Ultrastructure and synaptic targets of the raphe-nigral projection in the rat. Neuroscience 55, 417-427.
17. Cragg S. J., Rice M. E. and Greenfield S. A. (1994) Voltammetric characterization of electrically-stimulated somatodendritic dopamine release in mesencephalic slices. Sac. Neurosci. Abstr. 20, 473.1.
18. Cuello A. C. and Iversen L. L. (1978) Interactions of dopamine with other neurotransmitters in the substantia nigra: a possible functional role of dendritic dopamine. In Interactions Between Putative Neurotransmitters in the Brain (eds Garattini S., Pujol J. F. and Samanin R.), pp. 127-149. Raven Press, New York.
19. 3H]-dopamine in the dendrites of the dopaminergic neurons of the rat substantia nigra in vivo. Br. J. Pharmac. 59, 527-528.
20. Davidson C. and Stamford J. A. (1993) Neurochemical evidence of functional A10 dopamine terminals innervating the ventromedial axis of the neostriatum: in vitro voltammetric data in rat brain slices. Brain Res. 615, 229-239.
21. Elverfors A. and Nissbrandt H. (1991) Reserpine-insensitive dopamine release in the substantia nigra. Brain Res. 557, 5-12.
22. Fallon J. H. and Moore R. Y. (1978) Catecholamine innervation of basal forebrain. IV. Topography of the dopamine projection to the basal forebrain and striatum. J. comp. Neurol. 180, 545-580.
23. Geffen L. B., Jessell T. M., Cuello A. C. and Iversen L. L. (1976) Release of dopamine from dendrites in rat substantia nigra. Nature 260, 258-260.
24. Grace A. A. (1987) The regulation of dopamine neuron activity as determined by in vivo and in vitro intracellular recordings. In Neurophysiology of the Dopaminergic System: Current Status and Clinical Perspectives (eds Chiodo L. A. and Freeman A. S.), pp. 1-66. Lakeshore, Detroit.
25. Grace A. A. (1991) Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience 41, 1-24.
26. Hefti F. and Lichtensteiger W. (1978) Dendritic dopamine: studies on the release of endogenous dopamine from subcellular particles derived from dendrites of rat nigro-striatal neurons. Neurosci. Lett. 10, 65-70.
27. Invernizzi R., Belli S. and Samanin R. (1992) Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortex. Brain Res. 584, 322-324.
28. Iravani M. M. and Kruk Z. L. (1995) Effects of amphetamine on carrier-mediated and electrically stimulated dopamine release in slices of rat caudate putamen and nucleus accumbens. J. Neurochem. 64, 1161-1168.
29. Iravani M. M., Millar J., Muscat R. and Kruk Z. L. (1994) Dopamine release in the ventral tegmental area and nucleus accumbens compared. J. Physiol. 480, 71P.
30. Kalivas P. W., Bourdelais A., Abhold R. and Abbott L. (1989) Somatodendritic release of endogenous dopamine: in vivo dialysis in the A10 dopamine region. Neurosci. Lett. 100, 215-220.
31. Kalivas P. W. and Duffy P. (1988) Effects of daily cocaine and morphine treatment on somatodendritic and terminal field dopamine release. J. Neurochem. 50, 1498-1504.
32. Kalivas P. W. and Duffy P. (1991) A comparison of axonal and somatodendritic dopamine release using in vivo dialysis. J. Neurochem. 56, 961-967.
33. Kalivas P. W. and Stewart J. (1991) Dopamine transmission in the initiation and expression of drug-and stress-induced sensitization of motor activity. Brain Res. Rev. 16, 223-244.
34. Kamata K., Sugimoto A. and Kameyama T. (1986) In vivo voltammetric study of dopamine release in the striatum following microinjection of apomorphine into the substantia nigra zone reticulata. Jap. J. Pharmac. 40, 472-477.
35. Kamata K., Sugimoto A. and Kameyama T. (1986) Effect of chronic haloperidol on dopamine release following microinjection of GABA into the substantia nigra zone reticulata in the rat. Brain Res. 380, 1-6.
36. Kant G. J. and Meyerhoff J. L. (1978) Release of endogenous norepinephrine and dopamine from rat brain regions in vitro. Life Sci. 23, 2111-2118.
37. Kehr W., Speckenbach W. and Zimmermann R. (1977) Interaction of haloperidol and gamma-butyrolactone with (+)-amphetamine-induced changes in monoamine synthesis and metabolism in rat brain. J. neural Transm. 40, 129-147.
38. 3H]-dopamine is taken up and released from non-dopaminergic nerve terminals in the rat substantia nigra in vitro. J. Neurochem. 45, 137-144.
39. Kitt C. A., Cork L. C., Eidelberg F., Joh T. H. and Price D. L. (1986) Injury of nigral neurons exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: a tyrosine hydroxylase immunocytochemical study in monkey. Neuroscience 17, 1087-1103.
40. Klitenick M. A., Deutch A. Y., Churchill L. and Kalivas P. W. (1992) Topography and functional role of dopaminergic projections from the ventral mesencephalic tegmentum to the ventral pallidum. Neuroscience 50, 371-386.
41. Klockgether T. and Turski L. (1993) Toward an understanding of the role of glutamate in experimental Parkinsonism: agonist-sensitive sites in the basal ganglia, Ann. Neurol. 34, 585-593.
42. Korf J., Zieleman M. and Westerink B. H. C. (1976) Dopamine release in the substantia nigra. Nature 260, 257-258.
43. Lacey M. G., Mercuri N. B. and North R. A. (1987) Dopamine acts on D2 receptors to increase potassium conductance in neurones of the rat substantia nigra zone compacta. J. Physiol., Lond. 392, 397-416.
44. Lavoie B., Côté P.-Y. and Parent A. (1992) Immunohistochemical study of the basal ganglia in normal and parkinsonian monkeys. Adv. Neurol. 58, 115-121.
45. Lavoie B. and Parent A. (1990) Immunohistochemical study of the serotoninergic innervation of the basal ganglia in the squirrel monkey. J. comp. Neurol. 299, 1-16.
46. Lavoie B. and Parent A. (1994) Pedunculopontine nucleus in the squirrel monkey: cholinergic and glutamatergic projections to the substantia nigra. J. comp. Neurol. 344, 232-241.
47. Lavoie B. and Parent A. (1994) Pedunculopontine nucleus in the squirrel monkey: distribution of cholinergic and monoaminergic neurons in the mesopontine tegmentum with evidence for the presence of glutamate in cholinergic neurons. J. comp. Neurol. 344, 190-209.
48. Le Boulch N. L., Truong-Ngoc N. A. and Gauchy C. (1991) Role of dendritic dopamine of the substantia nigra in the modulation of nigrocollicular gamma-aminobutyric acid release: in vivo studies in the rat. J. Neurochem. 57, 1080-1083.
49. Limberger N., Trout S. J., Kruk Z. L. and Starke K. (1991) "Real time" measurement of endogenous dopamine release during short trains of pulses in slices of rat neostriatum and nucleus accumbens: role of autoinhibition. Naunyn-Schmiedeberg's Arch. Pharmac. 344, 623-629.
50. Llinás R., Greenfield S. A. and Jahnsen H. (1984) Electrophysiology of pars compacta cells in the in vivo substantia nigra - a possible mechanism for dendritic release. Brain Res. 294, 127-132.
51. Magnusson O., Mohringe B. and Fowler C. J. (1987) Comparison of the effects of dopamine D1 and D2 receptor antagonists on rat striatal, limbic and nigral dopamine synthesis and utilisation. J. neural Transm. 69, 163-177.
52. Mamounas L. A., Mullen C. A., O'Hearn E. and Molliver M. E. (1991) Dual serotoninergic projections to forebrain in the rat: morphologically distinct 5-HT axon terminals exhibit differential vulnerability to neurotoxic amphetamine derivatives. J. comp. Neurol. 314, 558-586.
53. Mamounas L. A., Wilson M. A., Axt K. J. and Molliver M. E. (1992) Morphological aspects of serotoninergic innervation. Adv. Biosci. 85, 97-118.
54. Marshall J. F., O'Dell S. J., Navarrete R. and Rosenstein A. J. (1990) Dopamine high-affinity transport site topography in rat brain: major differences between dorsal and ventral striatum. Neuroscience 37, 11-21.
55. Mayer R. A., Kindt M. V. and Heikkila R. E. (1986) Prevention of the nigrostriatal toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by inhibitors of 3,4-dihydroxyphenylethylamine transport. J. Neurochem. 47, 1073-1079.
56. McGeer P. L. and McGeer E. G. (1993) Neurotransmitters and their receptors in the basal ganglia. Adv. Neurol. 60, 93-101.
57. Millar J., O'Connor J. J., Trout S. J. and Kruk Z. L. (1992) Continuous scan cyclic voltammetry (CSCV): a new high-speed electrochemical method for monitoring neuronal dopamine release. J. Neurosci. Meth. 43, 109 118.
58. Mintz I., Hammond C., Guibert B. and Leviel V. (1986) Stimulation of the subthalamic nucleus enhances the release of dopamine in the rat substantia nigra. Brain Res. 376, 406-408.
59. Nedergaard S. and Greenfield S. A. (1992) Sub-populations of pars compacta neurons in the substantia nigra: the significance of qualitatively and quantitatively distinct conductances. Neuroscience 48, 423-437.
60. Nieoullon A., Cheramy A. and Glowinski J. (1977) Release of dopamine in vivo from cat substantia nigra. Nature 266, 375-377.
61. 2 receptors and to axotomy. J. neural Transm. 90, 13-26.
62. Nissbrandt H., Pileblad E. and Carlsson A. (1985) Evidence for dopamine release and metabolism beyond the control of nerve impulses and dopamine receptors in the rat substantia nigra. J. Pharm. Pharmac. 37, 884-889.
63. Nissbrandt H., Sundström E., Jonsson G., Hjorth S. and Carlsson A. (1989) Synthesis and release of dopamine in rat brain: comparison between substantia nigra pars compacta, pars reticulata, and striatum. J. Neurochem. 52, 1170-1182.
64. O'Connor J. J. and Kruk Z. L. (1994) Effects of 21 days treatment with fluoxetine on stimulated endogenous 5-hydroxytryptamine overflow in the rat dorsal raphe and suprachiasmatic nucleus studied using fast cyclic voltammetry in vitro. Brain Res. 640, 328-335.
65. Paden C., Wilson C. J. and Groves P. M. (1976) Amphetamine induced release of dopamine from the substantia nigra in vitro. Life Sci. 19, 1499-1506.
66. Palij P., Bull D. R., Sheehan M. J., Stamford J. A., Kruk Z. L. and Humphrey P. P. A. (1990) Presynaptic regulation of dopamine release in corpus striatum monitored in vitro in real time by fast cyclic voltammetry. Brain Res. 509, 172-174.
67. Patel J., Trout S. J. and Kruk Z. L. (1992) Regional differences in evoked dopamine efflux in brain slices of rat anterior and posterior caudate putamen. Naunyn-Schmiedeberg's Arch.-Pharmac. 346, 267-276.
68. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates. Academic Press, London.
69. Pazirek J., Hassler R. and Bak I. J. (1971) Light and electron microscopic autoradiography of substantia nigra of rat after intraventricular administration of tritium-labelled norepinephrine, dopamine, serotonin and the precursors. Z. Zellforsch. mikrosk. Anat. 115, 137-148.
70. Pileblad E. and Carlsson A. (1985) Catecholamine-uptake inhibitors prevent the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mouse brain. Neuropharmacology 24, 689-692.
71. Price R. H. Jr, Hollingsworth Z., Young A. B. and Penney J. B. Jr (1993) Excitatory amino acid receptor regulation after subthalamic nucleus lesions in the rat. Brain Res. 602, 157-160.
72. Rice M. E., Richards C. D., Nedergaard S., Hounsgaard J., Nicholson C. and Greenfield S. A. (1994) Direct monitoring of dopamine and 5-HT release in substantia nigra and ventral tegmental area in vitro. Expl Brain Res. 100, 395-406.
73. Robertson H. A. (1992) Dopamine receptor interactions: some implications for the treatment of Parkinson's disease. Trends Neurosci. 15, 201-206.
74. Rosales M. G., Flores G., Hernández S., Martínez-Fong D. and Aceves J. (1994) Activation of subthalamic neurons produces NMDA receptor-mediated dendritic dopamine release in substantia nigra pars reticulata: a microdialysis study in the rat. Brain Res. 645, 335-337.
75. Santiago M. and Westerink B. H. C. (1991) The regulation of dopamine release from nigrostriatal neurons in conscious rats: the role of somatodendritic autoreceptors. Eur. J. Pharmac. 204, 79-85.
76. Schuldiner S. (1994) A molecular glimpse of vesicular monoamine transporters. J. Neurochem. 62, 2067-2078.
77. Seutin V., Verbanck P., Massotte L. and Dresse A. (1991 ) Acute amphetamine-induced subsensitivity of AlO dopamine autoreceptors in vitro. Brain Res. 558, 141-144.
78. Stamford J. A., Kruk Z. L., Palij P. and Millar J. (1988) Diffusion and uptake of dopamine in rat caudate and nucleus accumbens compared using fast cyclic voltammetry. Brain Res. 448, 381-385.
79. Steinbusch H. W. M. (1981) Distribution of serotonin-immunoreactivity in the central nervous system of the rat cell bodies and terminals. Neuroscience 6, 557-618.
80. Stewart J. and Vezina P. (1989) Microinjections of SCH-23390 into the ventral tegmental area and substantia nigra pars reticulata attenuate the development of sensitization to the locomotor activating effects of systemic amphetamine. Brain Res. 495, 401-406.
81. Sulzer D., Maidment N. T. and Rayport S. (1993) Amphetamine and other weak bases act to promote reverse transport of dopamine in ventral midbrain neurons. J. Neurochem. 60, 527-535.
82. Sundstrom E., Goldstein M. and Jonsson G. (1986) Uptake inhibition protects nigro-striatal dopamine neurons from the neurotoxicity of 1-methyl-4-phenylpyridine (MPP+) in mice. Eur. J. Pharmac. 131, 289-292.
83. Tagerud S. E. and Cuello A. C. (1979) Dopamine release from the rat substantia nigra in vitro. Effect of raphe lesions and veratridine stimulation. Neuroscience 4, 2021-2029.
84. Trent F. and Tepper J. M. (1991) Dorsal raphe stimulation modifies striatal-evoked antidromic invasion of nigral dopaminergic neurons in vivo. Expl Brain Res. 84, 620-630.
85. Trout S. J. and Kruk Z. L. (1992) Differences in evoked dopamine efflux in rat caudate putamen, nucleus accumbens and tuberculum olfactorium in the absence of uptake inhibition: influence of autoreceptors. Br. J. Pharmac. 106, 452-458.
86. Trout S. J., Patel J. and Kruk Z. L. (1992) Monoamine efflux evoked by electrical stimulation in rat brain slices containing substantia nigra and ventral tegmental area. Br. J. Pharmac. 107, 217P.
87. Vezina P. (1993) Amphetamine injected into the ventral tegmental area sensitizes the nucleus accumbens dopaminergic response to systemic amphetamine: an in vivo microdialysis study in the rat. Brain Res. 605, 332-337.
88. Vezina P., Hervé D., Glowinski J. and Tassin J. P. (1994) Injections of 6-hydroxydopamine into the ventral tegmental area destroy mesolimbic dopamine neurons but spare the locomotor activating effects of nicotine in the rat. Neurosci. Lett. 168, 111-114.
89. Wang T. and French E. D. (1993) Effects of phencyclidine on spontaneous and excitatory amino acid-induced activity of ventral tegmental dopamine neurons: an extracellular in vitro study. Life Sci. 53, 49-56.
90. Wassef M., Berod A. and Sotelo C. (1992) Dopaminergic dendrites in the pars reticulata of the rat substantia nigra and their striatal input. Combined immunocytochemical localization of tyrosine hydroxylase and anterograde degeneration. Neuroscience 6, 2125-2139.
91. Westerink B. H. C., Santiago M. and De Vries J. B. (1992) The release of dopamine from nerve terminals and dendrites of nigrostriatal neurons induced by excitatory amino acids in the conscious rat. Naunyn-Schmiedeberg's Arch. Pharmac. 345, 523-529.
92. Westerink B. H. C., De Boer P., Santiago M. and De Vries J. B. (1994) Do nerve terminals and cell bodies of nigrostriatal dopaminergic neurons of the rat contain similar receptors? Neurosci. Lett. 167, 109-112.
93. White F. J. and Wang R. Y. (1983) Differential effects of classical and atypical antipsychotic drugs on A9 and A10 dopamine neurons. Science 221, 1054-1057.
94. White F. J. and Wang R. Y. (1983) Comparison of the effects of chronic haloperidol treatment on A9 and A10 dopamine neurons in the rat. Life Sci. 32, 983-993.
95. White F. J. and Wang R. Y. (1984) Pharmacological characterization of dopamine autoreceptors in the rat ventral tegmental area: microiontophoretic studies. J. Pharmac. exp. Ther. 231, 275-280.
96. Wieczorek W. J. and Kruk Z. L. (1994) A quantitative comparison of the effects of benztropine, cocaine and nomifensine on electrically evoked dopamine overflow and rate of re-uptake in the caudate putamen and nucleus accumbens in rat brain slice. Brain Res. 657, 42-50.
97. Williams J. and Davies J. A. (1983) The involvement of 5-hydroxytryptamine in the release of dendritic dopamine from slices of rat substantia nigra. J. Pharm. Pharmac. 35, 734-737.
98. Yeomans J. S., Mathur A. and Tampakeras M. (1993) Rewarding brain stimulation: role of tegmental cholinergic neurons that activate dopamine neurons. Behav. Neurosci. 107, 1077-1087.